PubMed Health⌕ Search

PubMed · 2183298

Ureteral neoplasms.

Abstract

The authors review primary and secondary neoplastic lesions of the ureter. Primary ureteral tumors are rare, although when they occur, they usually consist of transitional cell carcinoma. The most frequent symptoms are hematuria, frequency, dysuria, and pain. Secondary ureteral neoplasms are caused by direct extension from an adjacent extraureteral primary tumor or from a site of bulky metastasis and, rarely, by metastasis from a distant primary tumor. The most useful diagnostic modalities are retrograde pyelography for direct visualization of ureteral involvement--particularly in the presence of high-grade obstruction--and computed tomography for evaluation of extraureteral extent of tumors and the presence of lymphadenopathy and distant metastases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C S Winalski, J C Lipman, S S Tumeh. 1990. Ureteral neoplasms.. https://doi.org/10.1148/radiographics.10.2.2183298

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Trimodality treatment and selective organ preservation for bladder cancer.

Standard treatment for muscle-invasive bladder cancer is cystectomy. Trimodality treatment, including transurethral resection of the bladder tumor (TURBT), radiation therapy and chemotherapy, has been shown to produce survival rates comparable to those of cystectomy. With these programs, cystectomy has been reserved for patients with incomplete response or local relapse. During the past 15 years, organ preservation by trimodality treatment has been investigated in prospective series from single centers and cooperative groups, with more than 1,000 patients included. Five-year overall survival rates in the range of 50% to 60% have been reported, and approximately three quarters of the surviving patients maintained their bladder. Clinical criteria helpful in determining ideal patients for bladder preservation include early tumor stage (including high-risk T1 disease), a visibly complete TURBT, and absence of ureteral obstruction. Close coordination among all disciplines is required to achieve optimal results. Future investigations will focus on (1) optimizing radiation techniques and incorporating more effective systemic chemotherapy, and (2) the proper selection of patients based on molecular makers.

Carcinoma, Transitional Cell↗